Editor’s Note: This piece was part of a larger feature first published in our May 2002 issue. We are posting it because of news from the JUPITER trial, which is alluded to here.

In deciding whether a patient requires therapy to prevent an atherosclerosis-related heart attack or stroke, physicians usually rely heavily on measurements of cholesterol in the person’s blood. But that approach misses a great many vulnerable individuals. Several studies suggest that measuring blood concentrations of C-reactive protein – or CRP, a marker of inflammation – could add useful information. Indeed, in one recent report, Paul M. Ridker of Brigham and Women’s Hospital demonstrated that examining both CRP levels (which cannot be predicted from cholesterol measures) and cholesterol levels provides a more accurate indication of risk than assessing cholesterol alone.

Ridker grouped cholesterol levels in the general adult population into five progressively rising ranges (quintiles) and, separately, divided CRP levels into quintiles as well. Then he determined the relative risk faced by people having different combinations of cholesterol and CRP values. That is, he assigned a danger level of “one” to individuals whose cholesterol and CRP values both fell in the lowest quintile (front corner) and calculated how much that risk multiplied in adults having other permutations of cholesterol and CRP measurements.

He found that high CRP values signify markedly elevated risk for heart attack or stroke even in individuals with seemingly reassuring cholesterol values. For instance, people with average (third-quintile) cholesterol levels and the highest CRP levels face much the same peril as those who have the highest cholesterol and lowest CRP levels. And subjects having the highest values for both cholesterol and CRP confronted the greatest risk of all. Encouraged by such results, researchers now hope to undertake a large study assessing whether basing such treatment decisions on combined CRP and cholesterol testing will save lives.

3 Comments

1. 1. bucketofsquid 04:13 PM 11/13/08

   As a heart attack survivor I applaud anything that makes risk assessment more accurate. I had been encouraged to make exercise and diet changes but it came way too late to do any good.

   Reply | Report Abuse | Link to this

2. 2. Maria Tseng 04:00 PM 11/16/08

   The National Cholesterol Institute has published a set of Therapeutic Lifestyle Changes (TLC) http://www.nhlbi.nih.gov/chd/lifestyles.htm that in addition to diet, incudes exercise, relaxation... I am told that cardio arterial disease is largely reversible, that it's never too late. (Seems that Type II diabetes is also reversible with weight loss and diet.) A prominent cardiologist, T. Barry Levine, said his practice had successfully taken patients off the transplant list, by scrupulous adherence to TLC.
   
   BTW, the test for CRP, I think, is standard now in cardiology -- no longer new.
   
   Maria Tseng

   Reply | Report Abuse | Link to this

3. 3. quiapo 06:20 AM 6/8/09

   It would be good to know what are acceptable values.

   Reply | Report Abuse | Link to this